Development of Liposome Systems for Enhancing the PK Properties of Bivalent PROTACs
Proteolysis-Targeting Chimeras (PROTACs) are a promising new technology in drug development. They have rapidly evolved in recent years, with several of them in clinical trials. While most of these advances have been associated with monovalent protein degraders, bivalent PROTACs have also entered cli...
Saved in:
Main Authors: | Ponien Kou (Author), Elizabeth S. Levy (Author), An D. Nguyen (Author), Donglu Zhang (Author), Shu Chen (Author), Yusi Cui (Author), Xing Zhang (Author), Fabio Broccatelli (Author), Jennifer Pizzano (Author), Jennifer Cantley (Author), Elizabeth Bortolon (Author), Emma Rousseau (Author), Michael Berlin (Author), Peter Dragovich (Author), Vijay Sethuraman (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Non-small molecule PROTACs (NSM-PROTACs): Protein degradation kaleidoscope
by: Sinan Ma, et al.
Published: (2022) -
Estrogen Receptor-α Targeting: PROTACs, SNIPERs, Peptide-PROTACs, Antibody Conjugated PROTACs and SNIPERs
by: Arvind Negi, et al.
Published: (2022) -
PROTACs targeting epigenetic proteins
by: Chao Zhang, et al.
Published: (2023) -
Binary world/bivalent logic
by: Harald Kittler
Published: (2012) -
PROTACs for BRDs proteins in cancer therapy: a review
by: Chao Wang, et al.
Published: (2022)